Literature DB >> 24792121

Hypertension as a risk factor for heart failure.

Arun Kannan1, Rajesh Janardhanan.   

Abstract

Hypertension remains a significant risk factor for development of congestive heart failure CHF), with various mechanisms contributing to both systolic and diastolic dysfunction. The pathogenesis of myocardial changes includes structural remodeling, left ventricular hypertrophy, and fibrosis. Activation of the sympathetic nervous system and renin-angiotensin system is a key contributing factor of hypertension, and thus interventions that antagonize these systems promote regression of hypertrophy and heart failure. Control of blood pressure is of paramount importance in improving the prognosis of patients with heart failure.

Entities:  

Mesh:

Year:  2014        PMID: 24792121     DOI: 10.1007/s11906-014-0447-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  71 in total

Review 1.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors:  Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal:  Am J Med       Date:  2003-07       Impact factor: 4.965

2.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

Review 3.  Does load-induced ventricular hypertrophy progress to systolic heart failure?

Authors:  Kambeez Berenji; Mark H Drazner; Beverly A Rothermel; Joseph A Hill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07       Impact factor: 4.733

4.  Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program.

Authors:  N O Borhani; M D Blaufox; A Oberman; B F Polk
Journal:  Prog Cardiovasc Dis       Date:  1986 Nov-Dec       Impact factor: 8.194

5.  Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.

Authors:  R B Devereux; V Palmieri; N Sharpe; V De Quattro; J N Bella; G de Simone; J F Walker; R T Hahn; B Dahlöf
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

Review 6.  Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure.

Authors:  A T Hirsch; Y M Pinto; H Schunkert; V J Dzau
Journal:  Am J Cardiol       Date:  1990-10-02       Impact factor: 2.778

7.  Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.

Authors:  G de Simone; R B Devereux; M J Roman; A Ganau; P S Saba; M H Alderman; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

Review 8.  Left ventricular hypertrophy and clinical outcomes in hypertensive patients.

Authors:  Luis M Ruilope; Roland E Schmieder
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

9.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  24 in total

1.  Speckle tracking echocardiography assessment of global and regional contraction dysfunction in the mice model of pressure overload.

Authors:  Guan Wang; Le Zhang; Lei Ruan; Xiao-Qing Quan; Jun Yang; Cai-Xia Lv; Cun-Tai Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  Vasorelaxant activities and the underlying pharmacological mechanisms of Gynura procumbens Merr. leaf extracts on rat thoracic aorta.

Authors:  Zafar Iqbal; Idris Bello; Mohd Zaini Asmawi; Majed Ahmed Al-Mansoub; Ashfaq Ahmad; Qaiser Jabeen; Yam Mun Fei
Journal:  Inflammopharmacology       Date:  2017-11-28       Impact factor: 4.473

Review 3.  Unanswered Questions Regarding Blood Pressure Management for HF Prevention.

Authors:  Sergio H R Ramalho; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

4.  Chocolate consumption and risk of heart failure in the Physicians' Health Study.

Authors:  Andrew B Petrone; J Michael Gaziano; Luc Djoussé
Journal:  Eur J Heart Fail       Date:  2014-10-14       Impact factor: 15.534

Review 5.  Mouse Models of Heart Failure with Preserved or Reduced Ejection Fraction.

Authors:  Natalie A Noll; Hind Lal; W David Merryman
Journal:  Am J Pathol       Date:  2020-04-25       Impact factor: 4.307

Review 6.  Cardiac inositol 1,4,5-trisphosphate receptors.

Authors:  M Iveth Garcia; Darren Boehning
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-11-22       Impact factor: 4.739

7.  [A nomogram based on systemic inflammation markers can predict adverse outcomes in patients with heart failure].

Authors:  Z Liu; X Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

Review 8.  Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials.

Authors:  Ajai Chari; A Keith Stewart; Stuart D Russell; Philippe Moreau; Joerg Herrmann; Jose Banchs; Roman Hajek; John Groarke; Alexander R Lyon; George N Batty; Sunhee Ro; Mei Huang; Karim S Iskander; Daniel Lenihan
Journal:  Blood Adv       Date:  2018-07-10

9.  Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression.

Authors:  K Melissa Hallow; Charles H Van Brackle; Sommer Anjum; Sergey Ermakov
Journal:  Front Physiol       Date:  2021-06-16       Impact factor: 4.566

10.  Impact of Diabetes on Cardiac Function in Patients with High Blood Pressure.

Authors:  Nabila Soufi Taleb Bendiab; Souhila Ouabdesselam; Latefa Henaoui; Marilucy Lopez-Sublet; Jean-Jacques Monsuez; Salim Benkhedda
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.